Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19.
Martínez-Diz S, Marín-Benesiu F, López-Torres G, Santiago O, Díaz-Cuéllar JF, Martín-Esteban S, Cortés-Valverde AI, Arenas-Rodríguez V, Cuenca-López S, Porras-Quesada P, Ruiz-Ruiz C, Abadía-Molina AC, Entrala-Bernal C, Martínez-González LJ, Álvarez-Cubero MJ.
Martínez-Diz S, et al. Among authors: entrala bernal c.
Front Immunol. 2023 Mar 8;13:1094644. doi: 10.3389/fimmu.2022.1094644. eCollection 2022.
Front Immunol. 2023.
PMID: 36969980
Free PMC article.